Table 2.
Evolution of the main parameters evaluated.
| Parameter | Baseline | 6 months | P value | |
| Analytical parameters | ||||
|
|
CD4 lymphocyte (cell/µL), median (range) | 723 (166-1251) | 811 (178-1833) | .08 |
|
|
HIV-1 viral load <50 copies/mL, n (%) | 29 (96) | 28 (93) | .44 |
|
|
Total cholesterol, median (range) | 190 (106-306) | 178 (106-285) | .77 |
|
|
HDLa-cholesterol, median (range) | 49 (21-81) | 47 (23-94) | .24 |
|
|
LDLb-cholesterol, median (range) | 116 (37-190) | 108 (44-195) | .95 |
|
|
Triglycerides, median (range) | 115 (28-519) | 118 (50-274) | .19 |
| Adherence, n (%) | ||||
|
|
ARTc adherence >95% | 26 (87) | 27 (88) | .56 |
|
|
ART adherent (Simplified Medication Adherence Questionnaire) | 24 (80) | 22 (73) | .66 |
|
|
Non-ART adherent | 20 (66) | 17 (58) | .49 |
| Questionnaires | ||||
|
|
WHOQOL-BREF Physical quality of life (score) | 69 | 69 | .13 |
|
|
WHOQOL-BREF Psychological quality of life (score) | 75 | 78 | .19 |
|
|
WHOQOL-BREF Social relationships (score) | 69 | 69 | .32 |
|
|
WHOQOL-BREF Satisfaction with health care and social services (score) | 75 | 69 | .13 |
|
|
IPAQe: moderate-high activity, n (%) | 28 (93) | 27 (92) | .16 |
|
|
Perceived QOLf (score) | 4 | 4 | .22 |
|
|
Perceived health status (score) | 3 | 4 | .19 |
|
|
6-min walking test (meters) | 400 | 410 | .76 |
aHDL: High density lipoprotein.
bLDL: Low density lipoprotein.
cART: Antiretroviral Treatment.
dWHOQOL-BREF: World Health Organization Quality of Life Questionnaire (short version).
eIPAQ: International Physical Activity Questionnaire.
fQOL: Quality of life.